Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 24655436)

1.

Levels of brain natriuretic peptide are associated with peripheral arterial disease in subjects with type-2 diabetes mellitus.

Jin QH, Ye WL, Chen HH, He XJ, Li TL, Liu Q, Zhong L, Xu L, Han CM.

BMC Endocr Disord. 2014 Mar 21;14:27. doi: 10.1186/1472-6823-14-27.

2.

Increased serum N-terminal pro-B-type natriuretic peptide levels in patients with medial arterial calcification and poorly compressible leg arteries.

Jouni H, Rodeheffer RJ, Kullo IJ.

Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):197-202. doi: 10.1161/ATVBAHA.110.216770. Epub 2010 Oct 14.

3.

High Ankle-Brachial Index Indicates Cardiovascular and Peripheral Arterial Disease in Patients With Type 2 Diabetes.

Li Q, Zeng H, Liu F, Shen J, Li L, Zhao J, Zhao J, Jia W.

Angiology. 2015 Feb 24. pii: 0003319715573657. [Epub ahead of print]

PMID:
25712289
4.

Value of brain natriuretic peptide after acute myocardial infarction.

Güneş Y, Okçün B, Kavlak E, Erbaş C, Karcier S.

Anadolu Kardiyol Derg. 2008 Jun;8(3):182-7.

5.

Comparative study of galectin-3 and B-type natriuretic peptide as biomarkers for the diagnosis of heart failure.

Yin QS, Shi B, Dong L, Bi L.

J Geriatr Cardiol. 2014 Mar;11(1):79-82. doi: 10.3969/j.issn.1671-5411.2014.01.014.

6.

Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.

Agarwal AK, Singh M, Arya V, Garg U, Singh VP, Jain V.

J Assoc Physicians India. 2012 Jul;60:28-32.

PMID:
23405538
7.

B-type natriuretic peptide, vascular endothelial growth factor, endothelin-1, and nitric oxide synthase in chronic mountain sickness.

Ge RL, Mo VY, Januzzi JL, Jin G, Yang Y, Han S, Wood MJ, Levine BD.

Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1427-33. doi: 10.1152/ajpheart.00366.2010. Epub 2011 Jan 7.

9.

B-type natriuretic peptide testing for structural heart disease screening: a general population-based study.

Nakamura M, Tanaka F, Sato K, Segawa T, Nagano M.

J Card Fail. 2005 Dec;11(9):705-12. Erratum in: J Card Fail. 2006 Mar;12(2):170.

PMID:
16360967
10.

B-type natriuretic peptide level in the diagnosis of asymptomatic diastolic dysfunction.

Karaca I, Gülcü E, Yavuzkir M, Dağli N, Ilkay E, Ozbay Y, Işik A, Arslan N.

Anadolu Kardiyol Derg. 2007 Sep;7(3):262-7.

11.

Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.

Selim G, Stojceva-Taneva O, Spasovski G, Georgievska-Ismail L, Zafirovska-Ivanovska B, Gelev S, Dzekova P, Trajcevska L, Trojacanec-Piponska S, Sikole A.

Nephron Clin Pract. 2011;119(2):c162-70. doi: 10.1159/000327615. Epub 2011 Jul 8.

PMID:
21757955
12.

Sex-specific threshold levels of plasma B-type natriuretic peptide for prediction of cardiovascular event risk in a Japanese population initially free of cardiovascular disease.

Nakamura M, Tanaka F, Takahashi T, Makita S, Ishisone T, Onodera M, Ishibashi Y, Itai K, Onoda T, Ohsawa M, Tanno K, Sakata K, Shinichi O, Ogasawara K, Ogawa A, Kuribayashi T, Okayama A.

Am J Cardiol. 2011 Dec 1;108(11):1564-9. doi: 10.1016/j.amjcard.2011.07.011. Epub 2011 Aug 24.

PMID:
21871591
13.

Plasma B-type natriuretic peptide is useful for cardiovascular risk assessment in community-based diabetes subjects: comparison with albuminuria.

Onodera M, Nakamura M, Tanaka F, Takahashi T, Makita S, Ishisone T, Ishibashi Y, Itai K, Onoda T, Ohsawa M, Tanno K, Sakata K, Omama S, Ogasawara K, Ogawa A, Kuribayashi T, Sakamaki K, Okayama A.

Int Heart J. 2012;53(3):176-81.

14.

Plasma B-type natriuretic peptide measurement in a multiphasic health screening program.

Niinuma H, Nakamura M, Hiramori K.

Cardiology. 1998 Oct;90(2):89-94.

PMID:
9778544
15.

Association of cardiac and renal function with extreme N-terminal fragment pro-B-type natriuretic peptide levels in elderly patients.

Cui H, Huo G, Liu L, Fan L, Ye P, Cao J, Bai Y, Wang F, Hu Y.

BMC Cardiovasc Disord. 2012 Jul 26;12:57. doi: 10.1186/1471-2261-12-57.

16.

Cardiac risk scores in high-risk Hispanics and the predictive value of BNP.

Macabasco-O'Connell A, Danwalder S, Sinha K.

J Clin Nurs. 2011 Nov;20(21-22):3039-46. doi: 10.1111/j.1365-2702.2010.03661.x. Epub 2011 May 18.

PMID:
21592244
17.

Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population.

Nakamura M, Endo H, Nasu M, Arakawa N, Segawa T, Hiramori K.

Heart. 2002 Feb;87(2):131-5.

18.

Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock.

Ueda S, Nishio K, Akai Y, Fukushima H, Ueyama T, Kawai Y, Masui K, Yoshioka A, Okuchi K.

Shock. 2006 Aug;26(2):134-9.

PMID:
16878020
19.

Brain natriuretic peptide as a biomarker of systemic right ventricular function in patients with transposition of great arteries after atrial switch operation.

Chow PC, Cheung EW, Chong CY, Lun KS, Yung TC, Wong KT, Chau AK, Cheung YF.

Int J Cardiol. 2008 Jul 4;127(2):192-7. Epub 2007 Jul 23.

PMID:
17643533
20.

Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.

Kremastinos DT, Hamodraka E, Parissis J, Tsiapras D, Dima K, Maisel A.

Am Heart J. 2010 Jan;159(1):68-74. doi: 10.1016/j.ahj.2009.10.025.

PMID:
20102869
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk